Global Oncology Molecular Diagnostics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Publisher Name :
Date: 14-Jan-2021
No. of pages: 116

Based on the Oncology Molecular Diagnostics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Oncology Molecular Diagnostics market covered in Chapter 5:

HTG Molecular

Source MDx

Health Discovery

Eragen

GeneNews

Vermillion

Agendia

Orion Genomics

NorDiag

Hologic

Genomix Biotech

Beckman Coulter

Myriad Genetics

Becton.Dickinson and Company

Intergenetics

Genera Biosystems

QIAGEN

Angsana Molecular and Diagnostics

Kreatech Holding

Rosetta Genomics

Epigenomics

Predictive Biosciences

EXACT Sciences

Innogenetics

Prediction Sciences

BioMerieux

Nanosphere

Diagnocure

Asuragen

Cepheid

Nuvera Biosciences

Genomic Health

Exiqon

Autogenomics

Abbott Diagnostics

Cangen Biotechnologies

OncoMethylome Sciences

SensiGen

Roche Diagnostics

In Chapter 6, on the basis of types, the Oncology Molecular Diagnostics market from 2015 to 2025 is primarily split into:

Instruments

Reagents

In Chapter 7, on the basis of applications, the Oncology Molecular Diagnostics market from 2015 to 2025 covers:

Breast

Colorectal

Prostate

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Global Oncology Molecular Diagnostics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Oncology Molecular Diagnostics Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 HTG Molecular
5.1.1 HTG Molecular Company Profile
5.1.2 HTG Molecular Business Overview
5.1.3 HTG Molecular Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 HTG Molecular Oncology Molecular Diagnostics Products Introduction
5.2 Source MDx
5.2.1 Source MDx Company Profile
5.2.2 Source MDx Business Overview
5.2.3 Source MDx Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Source MDx Oncology Molecular Diagnostics Products Introduction
5.3 Health Discovery
5.3.1 Health Discovery Company Profile
5.3.2 Health Discovery Business Overview
5.3.3 Health Discovery Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Health Discovery Oncology Molecular Diagnostics Products Introduction
5.4 Eragen
5.4.1 Eragen Company Profile
5.4.2 Eragen Business Overview
5.4.3 Eragen Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Eragen Oncology Molecular Diagnostics Products Introduction
5.5 GeneNews
5.5.1 GeneNews Company Profile
5.5.2 GeneNews Business Overview
5.5.3 GeneNews Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 GeneNews Oncology Molecular Diagnostics Products Introduction
5.6 Vermillion
5.6.1 Vermillion Company Profile
5.6.2 Vermillion Business Overview
5.6.3 Vermillion Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Vermillion Oncology Molecular Diagnostics Products Introduction
5.7 Agendia
5.7.1 Agendia Company Profile
5.7.2 Agendia Business Overview
5.7.3 Agendia Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Agendia Oncology Molecular Diagnostics Products Introduction
5.8 Orion Genomics
5.8.1 Orion Genomics Company Profile
5.8.2 Orion Genomics Business Overview
5.8.3 Orion Genomics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Orion Genomics Oncology Molecular Diagnostics Products Introduction
5.9 NorDiag
5.9.1 NorDiag Company Profile
5.9.2 NorDiag Business Overview
5.9.3 NorDiag Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 NorDiag Oncology Molecular Diagnostics Products Introduction
5.10 Hologic
5.10.1 Hologic Company Profile
5.10.2 Hologic Business Overview
5.10.3 Hologic Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Hologic Oncology Molecular Diagnostics Products Introduction
5.11 Genomix Biotech
5.11.1 Genomix Biotech Company Profile
5.11.2 Genomix Biotech Business Overview
5.11.3 Genomix Biotech Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Genomix Biotech Oncology Molecular Diagnostics Products Introduction
5.12 Beckman Coulter
5.12.1 Beckman Coulter Company Profile
5.12.2 Beckman Coulter Business Overview
5.12.3 Beckman Coulter Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Beckman Coulter Oncology Molecular Diagnostics Products Introduction
5.13 Myriad Genetics
5.13.1 Myriad Genetics Company Profile
5.13.2 Myriad Genetics Business Overview
5.13.3 Myriad Genetics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Myriad Genetics Oncology Molecular Diagnostics Products Introduction
5.14 Becton.Dickinson and Company
5.14.1 Becton.Dickinson and Company Company Profile
5.14.2 Becton.Dickinson and Company Business Overview
5.14.3 Becton.Dickinson and Company Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Becton.Dickinson and Company Oncology Molecular Diagnostics Products Introduction
5.15 Intergenetics
5.15.1 Intergenetics Company Profile
5.15.2 Intergenetics Business Overview
5.15.3 Intergenetics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Intergenetics Oncology Molecular Diagnostics Products Introduction
5.16 Genera Biosystems
5.16.1 Genera Biosystems Company Profile
5.16.2 Genera Biosystems Business Overview
5.16.3 Genera Biosystems Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Genera Biosystems Oncology Molecular Diagnostics Products Introduction
5.17 QIAGEN
5.17.1 QIAGEN Company Profile
5.17.2 QIAGEN Business Overview
5.17.3 QIAGEN Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 QIAGEN Oncology Molecular Diagnostics Products Introduction
5.18 Angsana Molecular and Diagnostics
5.18.1 Angsana Molecular and Diagnostics Company Profile
5.18.2 Angsana Molecular and Diagnostics Business Overview
5.18.3 Angsana Molecular and Diagnostics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Angsana Molecular and Diagnostics Oncology Molecular Diagnostics Products Introduction
5.19 Kreatech Holding
5.19.1 Kreatech Holding Company Profile
5.19.2 Kreatech Holding Business Overview
5.19.3 Kreatech Holding Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Kreatech Holding Oncology Molecular Diagnostics Products Introduction
5.20 Rosetta Genomics
5.20.1 Rosetta Genomics Company Profile
5.20.2 Rosetta Genomics Business Overview
5.20.3 Rosetta Genomics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Rosetta Genomics Oncology Molecular Diagnostics Products Introduction
5.21 Epigenomics
5.21.1 Epigenomics Company Profile
5.21.2 Epigenomics Business Overview
5.21.3 Epigenomics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Epigenomics Oncology Molecular Diagnostics Products Introduction
5.22 Predictive Biosciences
5.22.1 Predictive Biosciences Company Profile
5.22.2 Predictive Biosciences Business Overview
5.22.3 Predictive Biosciences Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Predictive Biosciences Oncology Molecular Diagnostics Products Introduction
5.23 EXACT Sciences
5.23.1 EXACT Sciences Company Profile
5.23.2 EXACT Sciences Business Overview
5.23.3 EXACT Sciences Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.23.4 EXACT Sciences Oncology Molecular Diagnostics Products Introduction
5.24 Innogenetics
5.24.1 Innogenetics Company Profile
5.24.2 Innogenetics Business Overview
5.24.3 Innogenetics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.24.4 Innogenetics Oncology Molecular Diagnostics Products Introduction
5.25 Prediction Sciences
5.25.1 Prediction Sciences Company Profile
5.25.2 Prediction Sciences Business Overview
5.25.3 Prediction Sciences Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.25.4 Prediction Sciences Oncology Molecular Diagnostics Products Introduction
5.26 BioMerieux
5.26.1 BioMerieux Company Profile
5.26.2 BioMerieux Business Overview
5.26.3 BioMerieux Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.26.4 BioMerieux Oncology Molecular Diagnostics Products Introduction
5.27 Nanosphere
5.27.1 Nanosphere Company Profile
5.27.2 Nanosphere Business Overview
5.27.3 Nanosphere Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.27.4 Nanosphere Oncology Molecular Diagnostics Products Introduction
5.28 Diagnocure
5.28.1 Diagnocure Company Profile
5.28.2 Diagnocure Business Overview
5.28.3 Diagnocure Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.28.4 Diagnocure Oncology Molecular Diagnostics Products Introduction
5.29 Asuragen
5.29.1 Asuragen Company Profile
5.29.2 Asuragen Business Overview
5.29.3 Asuragen Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.29.4 Asuragen Oncology Molecular Diagnostics Products Introduction
5.30 Cepheid
5.30.1 Cepheid Company Profile
5.30.2 Cepheid Business Overview
5.30.3 Cepheid Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.30.4 Cepheid Oncology Molecular Diagnostics Products Introduction
5.31 Nuvera Biosciences
5.31.1 Nuvera Biosciences Company Profile
5.31.2 Nuvera Biosciences Business Overview
5.31.3 Nuvera Biosciences Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.31.4 Nuvera Biosciences Oncology Molecular Diagnostics Products Introduction
5.32 Genomic Health
5.32.1 Genomic Health Company Profile
5.32.2 Genomic Health Business Overview
5.32.3 Genomic Health Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.32.4 Genomic Health Oncology Molecular Diagnostics Products Introduction
5.33 Exiqon
5.33.1 Exiqon Company Profile
5.33.2 Exiqon Business Overview
5.33.3 Exiqon Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.33.4 Exiqon Oncology Molecular Diagnostics Products Introduction
5.34 Autogenomics
5.34.1 Autogenomics Company Profile
5.34.2 Autogenomics Business Overview
5.34.3 Autogenomics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.34.4 Autogenomics Oncology Molecular Diagnostics Products Introduction
5.35 Abbott Diagnostics
5.35.1 Abbott Diagnostics Company Profile
5.35.2 Abbott Diagnostics Business Overview
5.35.3 Abbott Diagnostics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.35.4 Abbott Diagnostics Oncology Molecular Diagnostics Products Introduction
5.36 Cangen Biotechnologies
5.36.1 Cangen Biotechnologies Company Profile
5.36.2 Cangen Biotechnologies Business Overview
5.36.3 Cangen Biotechnologies Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.36.4 Cangen Biotechnologies Oncology Molecular Diagnostics Products Introduction
5.37 OncoMethylome Sciences
5.37.1 OncoMethylome Sciences Company Profile
5.37.2 OncoMethylome Sciences Business Overview
5.37.3 OncoMethylome Sciences Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.37.4 OncoMethylome Sciences Oncology Molecular Diagnostics Products Introduction
5.38 SensiGen
5.38.1 SensiGen Company Profile
5.38.2 SensiGen Business Overview
5.38.3 SensiGen Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.38.4 SensiGen Oncology Molecular Diagnostics Products Introduction
5.39 Roche Diagnostics
5.39.1 Roche Diagnostics Company Profile
5.39.2 Roche Diagnostics Business Overview
5.39.3 Roche Diagnostics Oncology Molecular Diagnostics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.39.4 Roche Diagnostics Oncology Molecular Diagnostics Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Oncology Molecular Diagnostics Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Oncology Molecular Diagnostics Sales and Market Share by Types (2015-2020)
6.1.2 Global Oncology Molecular Diagnostics Revenue and Market Share by Types (2015-2020)
6.1.3 Global Oncology Molecular Diagnostics Price by Types (2015-2020)
6.2 Global Oncology Molecular Diagnostics Market Forecast by Types (2020-2025)
6.2.1 Global Oncology Molecular Diagnostics Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Oncology Molecular Diagnostics Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Oncology Molecular Diagnostics Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Oncology Molecular Diagnostics Sales, Price and Growth Rate of Instruments
6.3.2 Global Oncology Molecular Diagnostics Sales, Price and Growth Rate of Reagents
6.4 Global Oncology Molecular Diagnostics Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Instruments Market Revenue and Sales Forecast (2020-2025)
6.4.2 Reagents Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Oncology Molecular Diagnostics Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Oncology Molecular Diagnostics Sales and Market Share by Applications (2015-2020)
7.1.2 Global Oncology Molecular Diagnostics Revenue and Market Share by Applications (2015-2020)
7.2 Global Oncology Molecular Diagnostics Market Forecast by Applications (2020-2025)
7.2.1 Global Oncology Molecular Diagnostics Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Oncology Molecular Diagnostics Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Oncology Molecular Diagnostics Revenue, Sales and Growth Rate of Breast (2015-2020)
7.3.2 Global Oncology Molecular Diagnostics Revenue, Sales and Growth Rate of Colorectal (2015-2020)
7.3.3 Global Oncology Molecular Diagnostics Revenue, Sales and Growth Rate of Prostate (2015-2020)
7.3.4 Global Oncology Molecular Diagnostics Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Oncology Molecular Diagnostics Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Breast Market Revenue and Sales Forecast (2020-2025)
7.4.2 Colorectal Market Revenue and Sales Forecast (2020-2025)
7.4.3 Prostate Market Revenue and Sales Forecast (2020-2025)
7.4.4 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Oncology Molecular Diagnostics Sales by Regions (2015-2020)
8.2 Global Oncology Molecular Diagnostics Market Revenue by Regions (2015-2020)
8.3 Global Oncology Molecular Diagnostics Market Forecast by Regions (2020-2025)

9 North America Oncology Molecular Diagnostics Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Oncology Molecular Diagnostics Market Sales and Growth Rate (2015-2020)
9.3 North America Oncology Molecular Diagnostics Market Revenue and Growth Rate (2015-2020)
9.4 North America Oncology Molecular Diagnostics Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Oncology Molecular Diagnostics Market Analysis by Country
9.6.1 U.S. Oncology Molecular Diagnostics Sales and Growth Rate
9.6.2 Canada Oncology Molecular Diagnostics Sales and Growth Rate
9.6.3 Mexico Oncology Molecular Diagnostics Sales and Growth Rate

10 Europe Oncology Molecular Diagnostics Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Oncology Molecular Diagnostics Market Sales and Growth Rate (2015-2020)
10.3 Europe Oncology Molecular Diagnostics Market Revenue and Growth Rate (2015-2020)
10.4 Europe Oncology Molecular Diagnostics Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Oncology Molecular Diagnostics Market Analysis by Country
10.6.1 Germany Oncology Molecular Diagnostics Sales and Growth Rate
10.6.2 United Kingdom Oncology Molecular Diagnostics Sales and Growth Rate
10.6.3 France Oncology Molecular Diagnostics Sales and Growth Rate
10.6.4 Italy Oncology Molecular Diagnostics Sales and Growth Rate
10.6.5 Spain Oncology Molecular Diagnostics Sales and Growth Rate
10.6.6 Russia Oncology Molecular Diagnostics Sales and Growth Rate

11 Asia-Pacific Oncology Molecular Diagnostics Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Oncology Molecular Diagnostics Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Oncology Molecular Diagnostics Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Oncology Molecular Diagnostics Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Oncology Molecular Diagnostics Market Analysis by Country
11.6.1 China Oncology Molecular Diagnostics Sales and Growth Rate
11.6.2 Japan Oncology Molecular Diagnostics Sales and Growth Rate
11.6.3 South Korea Oncology Molecular Diagnostics Sales and Growth Rate
11.6.4 Australia Oncology Molecular Diagnostics Sales and Growth Rate
11.6.5 India Oncology Molecular Diagnostics Sales and Growth Rate

12 South America Oncology Molecular Diagnostics Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Oncology Molecular Diagnostics Market Sales and Growth Rate (2015-2020)
12.3 South America Oncology Molecular Diagnostics Market Revenue and Growth Rate (2015-2020)
12.4 South America Oncology Molecular Diagnostics Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Oncology Molecular Diagnostics Market Analysis by Country
12.6.1 Brazil Oncology Molecular Diagnostics Sales and Growth Rate
12.6.2 Argentina Oncology Molecular Diagnostics Sales and Growth Rate
12.6.3 Columbia Oncology Molecular Diagnostics Sales and Growth Rate

13 Middle East and Africa Oncology Molecular Diagnostics Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Oncology Molecular Diagnostics Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Oncology Molecular Diagnostics Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Oncology Molecular Diagnostics Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Oncology Molecular Diagnostics Market Analysis by Country
13.6.1 UAE Oncology Molecular Diagnostics Sales and Growth Rate
13.6.2 Egypt Oncology Molecular Diagnostics Sales and Growth Rate
13.6.3 South Africa Oncology Molecular Diagnostics Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source

List of Tables and Figures

Figure Product Picture
Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate 2015-2025
Table Oncology Molecular Diagnostics Key Market Segments
Figure Global Oncology Molecular Diagnostics Market Revenue ($) Segment by Type from 2015-2020
Figure Global Oncology Molecular Diagnostics Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Oncology Molecular Diagnostics
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table HTG Molecular Company Profile
Table HTG Molecular Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure HTG Molecular Production and Growth Rate
Figure HTG Molecular Market Revenue ($) Market Share 2015-2020
Table Source MDx Company Profile
Table Source MDx Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Source MDx Production and Growth Rate
Figure Source MDx Market Revenue ($) Market Share 2015-2020
Table Health Discovery Company Profile
Table Health Discovery Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Health Discovery Production and Growth Rate
Figure Health Discovery Market Revenue ($) Market Share 2015-2020
Table Eragen Company Profile
Table Eragen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eragen Production and Growth Rate
Figure Eragen Market Revenue ($) Market Share 2015-2020
Table GeneNews Company Profile
Table GeneNews Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GeneNews Production and Growth Rate
Figure GeneNews Market Revenue ($) Market Share 2015-2020
Table Vermillion Company Profile
Table Vermillion Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Vermillion Production and Growth Rate
Figure Vermillion Market Revenue ($) Market Share 2015-2020
Table Agendia Company Profile
Table Agendia Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Agendia Production and Growth Rate
Figure Agendia Market Revenue ($) Market Share 2015-2020
Table Orion Genomics Company Profile
Table Orion Genomics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Orion Genomics Production and Growth Rate
Figure Orion Genomics Market Revenue ($) Market Share 2015-2020
Table NorDiag Company Profile
Table NorDiag Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure NorDiag Production and Growth Rate
Figure NorDiag Market Revenue ($) Market Share 2015-2020
Table Hologic Company Profile
Table Hologic Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hologic Production and Growth Rate
Figure Hologic Market Revenue ($) Market Share 2015-2020
Table Genomix Biotech Company Profile
Table Genomix Biotech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genomix Biotech Production and Growth Rate
Figure Genomix Biotech Market Revenue ($) Market Share 2015-2020
Table Beckman Coulter Company Profile
Table Beckman Coulter Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Beckman Coulter Production and Growth Rate
Figure Beckman Coulter Market Revenue ($) Market Share 2015-2020
Table Myriad Genetics Company Profile
Table Myriad Genetics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Myriad Genetics Production and Growth Rate
Figure Myriad Genetics Market Revenue ($) Market Share 2015-2020
Table Becton.Dickinson and Company Company Profile
Table Becton.Dickinson and Company Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Becton.Dickinson and Company Production and Growth Rate
Figure Becton.Dickinson and Company Market Revenue ($) Market Share 2015-2020
Table Intergenetics Company Profile
Table Intergenetics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Intergenetics Production and Growth Rate
Figure Intergenetics Market Revenue ($) Market Share 2015-2020
Table Genera Biosystems Company Profile
Table Genera Biosystems Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genera Biosystems Production and Growth Rate
Figure Genera Biosystems Market Revenue ($) Market Share 2015-2020
Table QIAGEN Company Profile
Table QIAGEN Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure QIAGEN Production and Growth Rate
Figure QIAGEN Market Revenue ($) Market Share 2015-2020
Table Angsana Molecular and Diagnostics Company Profile
Table Angsana Molecular and Diagnostics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Angsana Molecular and Diagnostics Production and Growth Rate
Figure Angsana Molecular and Diagnostics Market Revenue ($) Market Share 2015-2020
Table Kreatech Holding Company Profile
Table Kreatech Holding Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Kreatech Holding Production and Growth Rate
Figure Kreatech Holding Market Revenue ($) Market Share 2015-2020
Table Rosetta Genomics Company Profile
Table Rosetta Genomics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Rosetta Genomics Production and Growth Rate
Figure Rosetta Genomics Market Revenue ($) Market Share 2015-2020
Table Epigenomics Company Profile
Table Epigenomics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Epigenomics Production and Growth Rate
Figure Epigenomics Market Revenue ($) Market Share 2015-2020
Table Predictive Biosciences Company Profile
Table Predictive Biosciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Predictive Biosciences Production and Growth Rate
Figure Predictive Biosciences Market Revenue ($) Market Share 2015-2020
Table EXACT Sciences Company Profile
Table EXACT Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure EXACT Sciences Production and Growth Rate
Figure EXACT Sciences Market Revenue ($) Market Share 2015-2020
Table Innogenetics Company Profile
Table Innogenetics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Innogenetics Production and Growth Rate
Figure Innogenetics Market Revenue ($) Market Share 2015-2020
Table Prediction Sciences Company Profile
Table Prediction Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Prediction Sciences Production and Growth Rate
Figure Prediction Sciences Market Revenue ($) Market Share 2015-2020
Table BioMerieux Company Profile
Table BioMerieux Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure BioMerieux Production and Growth Rate
Figure BioMerieux Market Revenue ($) Market Share 2015-2020
Table Nanosphere Company Profile
Table Nanosphere Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nanosphere Production and Growth Rate
Figure Nanosphere Market Revenue ($) Market Share 2015-2020
Table Diagnocure Company Profile
Table Diagnocure Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Diagnocure Production and Growth Rate
Figure Diagnocure Market Revenue ($) Market Share 2015-2020
Table Asuragen Company Profile
Table Asuragen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Asuragen Production and Growth Rate
Figure Asuragen Market Revenue ($) Market Share 2015-2020
Table Cepheid Company Profile
Table Cepheid Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cepheid Production and Growth Rate
Figure Cepheid Market Revenue ($) Market Share 2015-2020
Table Nuvera Biosciences Company Profile
Table Nuvera Biosciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nuvera Biosciences Production and Growth Rate
Figure Nuvera Biosciences Market Revenue ($) Market Share 2015-2020
Table Genomic Health Company Profile
Table Genomic Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genomic Health Production and Growth Rate
Figure Genomic Health Market Revenue ($) Market Share 2015-2020
Table Exiqon Company Profile
Table Exiqon Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Exiqon Production and Growth Rate
Figure Exiqon Market Revenue ($) Market Share 2015-2020
Table Autogenomics Company Profile
Table Autogenomics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Autogenomics Production and Growth Rate
Figure Autogenomics Market Revenue ($) Market Share 2015-2020
Table Abbott Diagnostics Company Profile
Table Abbott Diagnostics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott Diagnostics Production and Growth Rate
Figure Abbott Diagnostics Market Revenue ($) Market Share 2015-2020
Table Cangen Biotechnologies Company Profile
Table Cangen Biotechnologies Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cangen Biotechnologies Production and Growth Rate
Figure Cangen Biotechnologies Market Revenue ($) Market Share 2015-2020
Table OncoMethylome Sciences Company Profile
Table OncoMethylome Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure OncoMethylome Sciences Production and Growth Rate
Figure OncoMethylome Sciences Market Revenue ($) Market Share 2015-2020
Table SensiGen Company Profile
Table SensiGen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure SensiGen Production and Growth Rate
Figure SensiGen Market Revenue ($) Market Share 2015-2020
Table Roche Diagnostics Company Profile
Table Roche Diagnostics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Diagnostics Production and Growth Rate
Figure Roche Diagnostics Market Revenue ($) Market Share 2015-2020
Table Global Oncology Molecular Diagnostics Sales by Types (2015-2020)
Table Global Oncology Molecular Diagnostics Sales Share by Types (2015-2020)
Table Global Oncology Molecular Diagnostics Revenue ($) by Types (2015-2020)
Table Global Oncology Molecular Diagnostics Revenue Share by Types (2015-2020)
Table Global Oncology Molecular Diagnostics Price ($) by Types (2015-2020)
Table Global Oncology Molecular Diagnostics Market Forecast Sales by Types (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Sales Share by Types (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Revenue ($) by Types (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Revenue Share by Types (2020-2025)
Figure Global Instruments Sales and Growth Rate (2015-2020)
Figure Global Instruments Price (2015-2020)
Figure Global Reagents Sales and Growth Rate (2015-2020)
Figure Global Reagents Price (2015-2020)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate Forecast of Instruments (2020-2025)
Figure Global Oncology Molecular Diagnostics Sales and Growth Rate Forecast of Instruments (2020-2025)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate Forecast of Reagents (2020-2025)
Figure Global Oncology Molecular Diagnostics Sales and Growth Rate Forecast of Reagents (2020-2025)
Table Global Oncology Molecular Diagnostics Sales by Applications (2015-2020)
Table Global Oncology Molecular Diagnostics Sales Share by Applications (2015-2020)
Table Global Oncology Molecular Diagnostics Revenue ($) by Applications (2015-2020)
Table Global Oncology Molecular Diagnostics Revenue Share by Applications (2015-2020)
Table Global Oncology Molecular Diagnostics Market Forecast Sales by Applications (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Sales Share by Applications (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Oncology Molecular Diagnostics Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Breast Sales and Growth Rate (2015-2020)
Figure Global Breast Price (2015-2020)
Figure Global Colorectal Sales and Growth Rate (2015-2020)
Figure Global Colorectal Price (2015-2020)
Figure Global Prostate Sales and Growth Rate (2015-2020)
Figure Global Prostate Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate Forecast of Breast (2020-2025)
Figure Global Oncology Molecular Diagnostics Sales and Growth Rate Forecast of Breast (2020-2025)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate Forecast of Colorectal (2020-2025)
Figure Global Oncology Molecular Diagnostics Sales and Growth Rate Forecast of Colorectal (2020-2025)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate Forecast of Prostate (2020-2025)
Figure Global Oncology Molecular Diagnostics Sales and Growth Rate Forecast of Prostate (2020-2025)
Figure Global Oncology Molecular Diagnostics Market Revenue ($) and Growth Rate F
  • Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......
  • Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......
  • Global PSA Test Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global HPV Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......
  • Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102
    According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......
  • Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106
    The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......
  • Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......
  • Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs